BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity (Q28249553)
scientific article published on September 26, 1997
Language:
(P31) (Q13442814)
(P50) (Q138795)
(P304) 24101-4
(P407) (Q1860)
(P433) 39
(P478) 272
(P577) Friday, September 26, 1997
(P921) (Q14599311)
(Q14762999)
(P953) http://www.jbc.org/content/272/39/24101.full.pdf
https://api.elsevier.com/content/article/PII:S0021925819635647?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0021925819635647?httpAccept=text/plain
https://syndication.highwire.org/content/doi/10.1074/jbc.272.39.24101
(P1433) (Q867727)
(P1476) "BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity" (language: en)
"BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity" (language: en)
(P2093) J. Zha
H. Harada
K. Osipov
J. Jockel
G. Waksman
(P2860) (Q41099855)
(Q24312211)
(Q52514947)
(Q41229247)
(Q41206213)
(Q28586995)
(Q24648126)
(Q24320091)
(Q24311298)
(Q28297419)
(Q24302240)
(Q34300766)
(Q27733156)
(Q24561496)
(Q27734734)
(Q27861091)
other details
description scientific article published on September 26, 1997

External Links